Home Featured Page 13

Featured

Latest

Psychedelics Today Gifting Guide 2024

The Mystical Roots of Psychedelics: Exploring Dreams and the Liminal State

SCOOP: PSFC’s $130M Roadmap to Shape the Future of Psychedelic Philanthropy

Pα+ Psychedelic Bulletin #183:

Transpersonal Connections, the Body’s Memory, and the Collaborative Nature of Consciousness

Women’s Health and Psychedelics – New Insights

Regenerative Business in Psychedelics: A Sustainable Path Forward

Meditation, Exploring Spiritual Traditions, and the Wisdom of Plant Medicine

Regulation Beyond Prohibition: RAND Corporation Delivers Report on US Psychedelic Policymaking

Pα+ Psychedelic Bulletin #167: Lykos Insiders, Affiliates Respond to Critics; FDA-Affiliated...

Difficult Conversations, the Need for Culturally Competent Care, and Why Representation...

Archetypes, Individuation, and the Shadow: Carl Jung’s Enduring Psychedelic Influence

Vital 4: Informational Session and Q+A, with David

Vital 4: Informational Session and Q+A, with Diego

Vital 4: Informational Session and Q+A, with Kyle

1...121314...277 Page 13 of 277

EDITOR PICKS

Psychedelics Today Gifting Guide 2024

The Mystical Roots of Psychedelics: Exploring Dreams and the Liminal State

SCOOP: PSFC’s $130M Roadmap to Shape the Future of Psychedelic Philanthropy

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Psychedelics Today Gifting Guide 2024

The Mystical Roots of Psychedelics: Exploring Dreams and the Liminal State

SCOOP: PSFC’s $130M Roadmap to Shape the Future of Psychedelic Philanthropy

Pα+ Psychedelic Bulletin #183:

Transpersonal Connections, the Body’s Memory, and the Collaborative Nature of Consciousness

Women’s Health and Psychedelics – New Insights

Regenerative Business in Psychedelics: A Sustainable Path Forward

Meditation, Exploring Spiritual Traditions, and the Wisdom of Plant Medicine

Regulation Beyond Prohibition: RAND Corporation Delivers Report on US Psychedelic Policymaking

Pα+ Psychedelic Bulletin #167: Lykos Insiders, Affiliates Respond to Critics; FDA-Affiliated...

Difficult Conversations, the Need for Culturally Competent Care, and Why Representation...

Archetypes, Individuation, and the Shadow: Carl Jung’s Enduring Psychedelic Influence

Vital 4: Informational Session and Q+A, with David

Vital 4: Informational Session and Q+A, with Diego

Vital 4: Informational Session and Q+A, with Kyle

EDITOR PICKS

Psychedelics Today Gifting Guide 2024

The Mystical Roots of Psychedelics: Exploring Dreams and the Liminal State

SCOOP: PSFC’s $130M Roadmap to Shape the Future of Psychedelic Philanthropy

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY